![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.347, 2002-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reference drug-pricing systems in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug-pricing issue hotting up in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novartis' drug pricing, information causing friction
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 377, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug pricing: what's to be done?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
India moves forward with new drug pricing policy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. :